1. Sandstede JJ. Assessment of myocardial viability by MR imaging. Eur Radiol. 2003. 13:52–61.
2. Abdel-Aty H, Zagrosek A, Schulz-Menger J, Taylor AJ, Messroghli D, Kumar A, et al. Delayed enhancement and T2-weighted cardiovascular MRI differentiate acute form chronic myocardial infarction. Circulation. 2004. 109:2411–2416.
3. Choi SI, Lee KW, Kang SK, Ryu WH, Lim C, Chou JH, et al. Usefulness of breath-hold T2-weighted MR imaging in patients with myocardial infarction: comparison with delayed enhancement. J Korean Soc Magn Reson Med. 2003. 7:132–136.
4. Barkhausen J, Ruehm SG, Goyen M, Buck T, Laub G, Debatin JF. MR evaluation of ventricular function: True fast image with steady-state precession versus fast low angle shot cine MR imaging: Feasibility study. Radiology. 2001. 219:264–269.
5. Choi B, Choe KO, Kim Y, Chung H, Chung N, Choi D. Contrast-enhanced cine magnetic resonance imaging with balanced turbo field echo in myocardial infarction. RSNA program book. 2003. 251–252.
6. Chen Q, Storey P, Prased P, Li W, Mai V, Huang R, et al. Simultaneous imaging of myocardial function and viability. In : ISMRM 2003 Exhibition;
7. Baer FM, Voth E, Schneider CA, Theissen P, Schicha H, Sechtem U. Comparison of low-dose dobutamine-gradient-echo magnetic resonance imaging and positron emission tomography with 18F-fluorodeoxyglucose in patients with chronic coronary artery disease. A functional and morphological approach to the detection of residual myocardial viability. Circulation. 1995. 91:1006–1015.
8. Silver Malcolm D, Gotlieb A, Schoen FJ. Cardiovascular pathology. 2001. 3rd ed. Philadelphia: Churchill Livingstone;233–235.
9. Simonetti OP, Kim RJ, Fieno DS, Hillenbrand HB, Wu E, Bundy JM, et al. An improved MR imaging technique for the visualization of myocardial infarction. Radiology. 2001. 218:215–223.
10. Fuchs F, Laub G, Othomo K. True FISP-technical considerations and cardiovascular applications. Eur J Radiol. 2003. 46:28–32.
11. Winer-Muram HT, Tann M, Aisen AM, Ford L, Jennings SG, Bretz R. Computed tomography demonstration of lipomatous metaplasia of the left ventricle following myocardial infarction. J Comput Assist Tomogr. 2004. 28:455–458.
12. Oshinski JN, Yang Z, Jones JR, Mata JF, French BA. Imaging time after Gd-DTPA injection is critical in using delayed enhancement to determine infarct size accurately with magnetic resonance imaging. Circulation. 2001. 104:2838–2842.
13. Thomson RJ, Kim RJ, Judd RM. MRI for the assessment of myocardial viability. J Magn Reson Imaging. 2004. 19:771–788.